Territory Manager THV
Edwards Lifesciences
Territory Manager THV
Edwards Lifesciences
Develops transcatheter heart valves and devices
Territory Manager
Location: Calgary or Edmonton
The Territory Manager is responsible for driving sales growth and market expansion of THV therapies within an assigned geography. By combining commercial excellence, strategic account management, and market development the Territory Manager identifies and executes opportunities to expand patient access, strengthen referral networks, increase treatment capacity, and accelerate adoption of THV therapies. Success is measured through achievement of business objectives, growth in therapy utilization, expansion of customer relationships, and development of sustainable programs that enable more patients to receive appropriate treatment.
Job Description
Applies advanced clinical, commercial, and strategic expertise to drive adoption and growth of THV therapies across territory. Leads territory and account growth strategies by identifying opportunities to increase patient identification, referral activity, procedural capacity, and therapy utilization. Acts as a trusted partner to physicians, administrators, and healthcare stakeholders to develop customer-focused solutions that improve patient access while delivering sustainable business growth and market share expansion.
How you will make an impact:
What you will need:
For Canada, the base pay range for this position is 92 000 $ - 133 000 $ (highly experienced). The pay for the successful candidate will depend on various factors (e.g., qualifications, education, prior experience). Aligning our overall business objectives with performance, we offer competitive salaries, performance-based incentives, and a wide variety of benefits programs to address the diverse individual needs of our employees and their families.
Develops transcatheter heart valves and devices
Edwards Lifesciences focuses on cardiovascular medical technologies, especially transcatheter heart valves. Its products enable repairing or replacing diseased heart valves through minimally invasive procedures rather than open-heart surgery. The company builds on a long history that began with the Starr-Edwards valve and now centers on valve therapies and related diagnostics to treat heart disease. It differentiates itself by specializing in valve technologies and transcatheter approaches, backed by a track record of clinical leadership and global reach. The goal is to improve patient outcomes by providing safer, less invasive valve treatment options for people around the world.
Explore more opportunities at Edwards Lifesciences